Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

To compare the efficacy and toxicities of pemetrexed plus platinum with other platinum regimens in patients with previously untreated advanced non-small cell lung cancer (NSCLC). Methods: A meta-analysis was performed using trials identified through PubMed, EMBASE, and Cochrane databases. Two invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming, Zhang, Qian, Fu, Peifang, Li, Ping, Peng, Aimei, Zhang, Guoliang, Song, Xiaolian, Tan, Min, Li, Xuan, Liu, Yang, Wu, Yueping, Fan, Suyun, Wang, Changhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355109/
https://www.ncbi.nlm.nih.gov/pubmed/22615946
http://dx.doi.org/10.1371/journal.pone.0037229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355109/
https://www.ncbi.nlm.nih.gov/pubmed/22615946
http://dx.doi.org/10.1371/journal.pone.0037229

Ejemplares similares